CVR number 85169017
Industry 32.5000 Manufacture of medical and dental instruments and supplies

ORTOPÆDISKOMAGERIET ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Bankruptcy risk for industry  2.2% 2.2% 2.2% 2.2% 2.2%  
Bankruptcy risk  5.2% 7.8% 2.4% 1.6% 0.9%  
Credit score (0-100)  44 31 62 74 86  
Credit rating  BBB BB BBB A A  
Credit limit (kDKK)  -0.0 -0.0 0.0 9.9 523.7  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales  0 0 0 0 0  
Gross profit  8,353 10,435 10,823 12,481 15,289  
EBITDA  -576 796 -116 1,658 2,926  
EBIT  -791 405 -620 1,096 2,142  
Pre-tax profit (PTP)  -1,287.0 69.0 -840.0 943.0 2,076.3  
Net earnings  -1,156.0 202.0 -486.0 943.0 2,147.0  
Pre-tax profit without non-rec. items  -1,287 69.0 -840 943 2,076  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Tangible assets total  986 1,235 1,514 1,428 1,187  
Shareholders equity total  -4,261 -4,058 1,571 2,514 3,911  
Interest-bearing liabilities  8,404 5,161 1,551 838 0.0  
Balance sheet total (assets)  7,694 9,477 9,616 9,608 9,558  
Net Debt  8,379 4,131 1,478 817 -361  
 
See the entire balance sheet

Volume 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  8,353 10,435 10,823 12,481 15,289  
Gross profit growth  -13.5% 24.9% 3.7% 15.3% 22.5%  
Employees  18 18 18 23 24  
Employee growth %  -10.0% 0.0% 0.0% 27.8% 4.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  7,694 9,477 9,616 9,608 9,558  
Balance sheet change%  -5.9% 23.2% 1.5% -0.1% -0.5%  
Added value  -576.0 796.0 -116.0 1,600.0 2,926.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  150 -51 -320 -814 -1,119  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -4.0 1.0 -1.0 1.0 2.0  

Profitability 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -9.5% 3.9% -5.7% 8.8% 14.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -6.7% 3.3% -5.1% 11.7% 22.5%  
ROI %  -9.4% 5.5% -10.9% 29.6% 59.5%  
ROE %  -14.6% 2.4% -8.8% 46.2% 66.8%  

Solidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Equity ratio %  -35.6% -30.0% 16.4% 26.3% 41.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -1,454.7% 519.0% -1,274.1% 49.3% -12.4%  
Gearing %  -197.2% -127.2% 98.7% 33.3% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  6.3% 5.3% 7.6% 15.3% 20.2%  

Liquidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Quick Ratio  0.4 0.9 0.9 1.0 1.4  
Current Ratio  0.6 1.0 1.0 1.2 1.6  
Cash and cash equivalent  25.0 1,030.0 73.0 21.0 361.5  

Capital use efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -4,654.0 146.0 139.0 1,165.0 2,897.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales / employee  0 0 0 0 0  
Added value / employee  -32 44 -6 70 122  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -32 44 -6 72 122  
EBIT / employee  -44 23 -34 48 89  
Net earnings / employee  -64 11 -27 41 89